New cancer chemotherapy drugs in Europe.
作者信息
Mathé G, van Putten L M
出版信息
Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141.
PMID:373907
Abstract
摘要
相似文献
1
New cancer chemotherapy drugs in Europe.
Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141.
2
[Chemotherapy of malignant gynecologic tumors].[恶性妇科肿瘤的化疗]
J Gynecol Obstet Biol Reprod (Paris). 1976 Mar;5(2):297-9.
3
Cancer chemotherapy. Current status, coming innovations.癌症化疗。现状与未来创新。
Postgrad Med. 1983 Jan;73(1):125-30. doi: 10.1080/00325481.1983.11698318.
4
[Chemotherapy for digestive carcinomas. General principles (author's transl)].
Nouv Presse Med. 1978 Nov 25;7(41):3749-52.
5
Cancer chemotherapy.癌症化疗
Med Lett Drugs Ther. 1983 Jan 7;25(626):1-8.
6
Modern cancer chemotherapy.现代癌症化疗
Indian J Pediatr. 1983 Nov-Dec;50(407):651-9. doi: 10.1007/BF02957735.
7
Antineoplastic chemotherapy.
South Med J. 1977 Jul;70(7):847-54. doi: 10.1097/00007611-197707000-00025.
8
[Cancer chemotherapy (author's transl)].[癌症化疗（作者译）]
Rev Med Chil. 1978 Oct;106(10):797-800.
9
[Cancer chemotherapy: a challenge to take up].
Infirm Can. 1979 Apr;21(4):18-26.
10
General principles of cancer chemotherapy.
Conn Med. 1976 Mar;40(3):159-68.
本文引用的文献
1
Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology).乳酸甲氧基 - 9 - 玫瑰树碱。I. 实验研究（抑癌和免疫抑制作用；临床前药理学）
Rev Eur Etud Clin Biol. 1970 May;15(5):534-8.
2
Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia.
Rev Eur Etud Clin Biol. 1970 May;15(5):541-5.
3
Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole.甲硝唑对实体瘤缺氧细胞放射增敏作用的证明。
Br J Radiol. 1974 Jul;47(559):399-404. doi: 10.1259/0007-1285-47-559-399.
4
New platinum complexes with anti-tumour activity.
Chem Biol Interact. 1972 Nov;5(6):415-24. doi: 10.1016/0009-2797(72)90078-6.
5
Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).1,2:5,6-二去水半乳糖醇（NSC-132313）的药理及抗肿瘤作用
Cancer Chemother Rep. 1972 Oct;56(5):593-602.
6
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Cancer. 1974 Oct;34(4):985-92. doi: 10.1002/1097-0142(197410)34:4<985::aid-cncr2820340402>3.0.co;2-u.
7
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
Br Med J. 1973 Jul 28;3(5873):199-202.
8
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.恶性淋巴瘤和实体瘤中表鬼臼毒素VM26的临床筛查
Br Med J. 1972 Jun 24;2(5816):744-8.
9
Biologic activity of some adriamycin (NSC-123127) derivatives.某些阿霉素（NSC - 123127）衍生物的生物活性。
Cancer Chemother Rep. 1974 Nov-Dec;58(6):769-76.
10
A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.一种新型抗肿瘤药物：9-羟基玫瑰树碱。在DNA嵌入药物系列中合理设计抗癌药物的可能性。
Proc Natl Acad Sci U S A. 1974 Dec;71(12):5078-82. doi: 10.1073/pnas.71.12.5078.
Zotero 插件